
Feb 5 (Reuters) - Imunon Inc IMNN.O:
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY
IMUNON INC - STRATEGIC RESTRUCTURING TO CUT NON-ESSENTIAL EXPENSES
IMUNON INC: PHASE 3 STUDY ENROLLMENT REMAINS AHEAD OF SCHEDULE AND ADVANCES COMPANY TOWARD FUTURE BLA FILING
IMUNON INC: ANNOUNCES STRATEGIC REORGANIZATION THAT WILL ELIMINATE HEADCOUNT NOT ESSENTIAL TO PHASE 3 TRIAL
IMUNON INC - KHURSHEED ANWER TO RETIRE AS EVP AND CSO